Detalhe da pesquisa
1.
Unilateral Choanal Atresia: Indications of Long-Term Olfactory Deficits and Volumetric Brain Changes Postsurgically.
ORL J Otorhinolaryngol Relat Spec
; 84(2): 89-92, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839294
2.
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas.
J Pathol
; 251(4): 378-387, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462735
3.
Gustatory pathway in humans: A review of models of taste perception and their potential lateralization.
J Neurosci Res
; 97(3): 230-240, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30168865
4.
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.
Genet Med
; 21(3): 705-717, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30050099
5.
Correction to: DNA methylation-based reclassification of olfactory neuroblastoma.
Acta Neuropathol
; 136(3): 505, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094618
6.
DNA methylation-based reclassification of olfactory neuroblastoma.
Acta Neuropathol
; 136(2): 255-271, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29730775
7.
Testicular cancer patients undergoing cisplatin based chemotherapy exhibit temporary olfactory threshold scores changes.
Eur Arch Otorhinolaryngol
; 274(7): 2813-2818, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28429112
8.
The administration of nasal drops in the "Kaiteki" position allows for delivery of the drug to the olfactory cleft: a pilot study in healthy subjects.
Eur Arch Otorhinolaryngol
; 273(4): 939-43, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26141752
9.
Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure.
Acta Oncol
; 54(9): 1355-63, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26398663
10.
The impact and prospect of traumatic brain injury on olfactory function: a cross-sectional and prospective study.
Eur Arch Otorhinolaryngol
; 271(6): 1533-40, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24071856
11.
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts.
Radiother Oncol
; 191: 110055, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109944
12.
PET/MRI in head and neck cancer: initial experience.
Eur J Nucl Med Mol Imaging
; 40(1): 6-11, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23053322
13.
Intrinsic chemosensory signal recorded from the human nasal mucosa in patients with smell loss.
Eur Arch Otorhinolaryngol
; 270(4): 1335-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23053385
14.
Influence of background noise on the performance in the odor sensitivity task: effects of noise type and extraversion.
Exp Brain Res
; 222(1-2): 89-97, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22941357
15.
Improvement of chronic rhinitis under aspirin.
Respir Care
; 57(3): 460-3, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22005504
16.
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
Endocr Relat Cancer
; 29(4): 213-224, 2022 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35171114
17.
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy.
Radiother Oncol
; 167: 300-307, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999136
18.
Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
Radiother Oncol
; 169: 8-14, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182686
19.
Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy.
Radiother Oncol
; 171: 91-100, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429503
20.
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT.
Cancers (Basel)
; 14(12)2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740697